Your doctor will be the best judge of this
GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
M1 macrophages, typically activated by IFN-, are characterized by the production of IL-1, TNF-, IL-6, and iNOS, and are closely associated with synovial inflammation and tissue destruction (106)
Vitamin C can be taken at the same time to provide antioxidant support
Synthesized B12 is commonly referred to as cyanocobalamin